GPT and metabolic dysfunction-associated steatotic liver disease: All 4 studies focusing on pediatric patients with NAFLD (43–46) evaluated the ALT change, but 2 out of 4 reported that probiotics might not be capable to reduce ALT level compared with a placebo (44, 45).